PSC2002/L23 PK and Protein Phosphatases Flashcards

1
Q

What can activate protein kinases?

A

cGMP (PKG)
Increase in Ca2+
PKB & protein tyrosine kinases (only phosphorylate serine residues)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the key difference between the cGMP and cAMP signalling pathways?

A

GPCRs not involved in cGMP pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 2 distinct types of GCs?

A

Soluble form (sGC) activated by NO
Plasma membrane bound (pGC) activated by peptide agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give another abbreviation of PKG.

A

cGK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the role of cGMP in the cGMP pathway?

A

Activates PKG
PKG phosphorylates serine/threonine residues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What breaks down cGMP?

A

cGMP-dependent PDEs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can nitric oxide production be stimulated?

A

Increasing calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How permeable are endothelial cells to NO?

A

Very permeable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where is ANP released from?

A

Atrial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can a singular peptide increase cGMP? (3)

A

Binds to plasma membrane
Covalent change in guanylyl cyclase
Leads to increase in catalytic subunits which make cGMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where is NO released from?

A

Endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the effect of NO in VSM?

A

Activates sGC/cGMP
Vasodilation and BP decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What kind of drugs are used to treat angina?

A

NO generating drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What kind of drug is Viagra (sildenafil)?

A

Type 5 cGMP PDE inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the effect of viagra (sildenafil)? What is it used to treat? (2)

A

Rise in cGMP relaxes SM in some tissues
Used to treat erection problems and pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the effect og heat stable enterotoxin from E. coli in the intestine. (3)

A

Activates pGC/cGMP
PKG phosphorylates & activates CFTR
Leads to secretory diarrhoea

17
Q

Describe the LPS (endotoxin) from Gram -ve bacteria. (3)

A

Increases iNOS (inducible NO synthase) expression
Excessive NO production
Can lead to clinical shock due to severe BP drop

18
Q

How many different isoforms and groups of PKC are there?

A

11 isoforms
3 groups - conventional, novel and atypical

19
Q

What is required for PKC to become active?

A

Phospholipid binding

20
Q

What keeps PKC inactive? (2)

A

R domain has a pseudosubstrate motif
Keeps kinase inactive by occupying substrate binding site on C4 domain

21
Q

Describe the activation cycle for cPKC (following a rise in cytosolic Ca2+). (3)

A

Ca2+ binds to C2 domain
PKC translocates to PM to bind DAG via C1 domain
PS motif disengages from C4 domain, allowing substrates to bind and be phosphorylated

22
Q

How can cPKC be artificially activated? (2)

A

Phorbol esters (plant alkaloids which are tumorigenic)
Directly bind to PKC

23
Q

What are the 2 main types of Ca2+/Calmodulin-dependent Protein Kinases?

A

Those with narrow substrate specificities (e.g., phosphorylase kinase only phosphorylates ‘phosphorylase’
Those with broad substrate specificities (e.g., Multifunctional CaM kinase II (CaMKII) which phosphorylates many substrates)

24
Q

Give 3 functions of CaMKII.

A
  1. Regulates N-methyl-D-aspartate (NMDA) receptors by phosphorylating sites on NR2A and NR2B subunits
  2. Enhances InsP3 formation by inhibiting inositol phosphorylate 5-phosphatase
  3. Central role in frequency decoding of calcium signals and acting as molecular switch in learning and memory
  4. Phosphorylates PLB to control SERCA2 pump - works in synergy with PKA to inhibit PLB effect on SERCA
25
Q

What is the function of protein phosphatases (PP)?

A

Remove phosphate groups from phosphorylated proteins (Ser/Thr & Tyr residues)

26
Q

What are the 4 major classes of Ser/Thr PPs?

A

1, 2A, 2B, 2C
1, 2A, 2C show broad & overlapping substrate specificity
“B (calcineurin- CaN) has more restricted specificity & requires Ca2+/CaM activity

27
Q

How are PPs regulated?

A

By inhibitory proteins type 1 and 2

28
Q

Give an additional class of PPs.

A

Tyrosine PPs, in membrane bound and cytosolic forms

29
Q

Give 2 chemical inhibitors of protein phosphatases and what they block.

A

Okadaic acid (OA) blocks PP1 and PP2A
Cyclosporin A very specific for calcineurin (PP2B) used clinically for immunosuppression via effects on T-cells

30
Q

Where does okadaic acid originate from?

A

Dinoflagellates (algae) produce this toxin
Accumulates in marine sponges and shellfish
When ingested causes diarrhetic shellfish poisoning (DSP)

31
Q

How does diarrhetic shellfish poisoning (caused by okadaic acid) cause acute diarrhoea?

A

Increased paracellular permeability
More active CFTR, promoting fluid loss from GI tract

32
Q

How does PKA lead to glycolysis? (3)

A

Switch on PKA through GPCR
Phosphorylates PK to A form
Glycogen breakdown

33
Q

What is the role of PKA with regards to PP inhibitory proteins?

A

Activate PP ‘inhibitory’ proteins
Inhibitory proteins bind to and inhibit PPs during glycogen breakdown
Rise in [cAMP] favours glycogen breakdown

34
Q

Describe the synergy between cAMP and Ca2+ in skeletal muscle. (2)

A

Link between depolarisation and opening of Ca2+ stores
Ca2+ feeds into PK helping it to work better

35
Q

What are the requirements of PK to work in skeletal muscle?

A

PKA phosphorylation and Ca2+ binding

36
Q

What are the subunits of PK?

A

a, B, d, Y
PKA phosphorylation of a and B subunits increases calcium sensitivity of PK

37
Q

Which 2 signalling pathways interact to regulate insulin secretion from beta cells?

A

cAMP signalling and tyrosine kinase signalling pathways